[Skip to Content]
[Skip to Content Landing]
Views 503
Citations 0
Editor's Correspondence
May 28, 2012

Dabigatran and Myocardial Infarction: Meta-Illusion?

Author Affiliations

Author Affiliations: School of Medicine and Public Health, Salvador, Brazil (Dr Correia); and School of Medicine, Federal University of Bahia, Bahia, Brazil (Dr Lopes).

Arch Intern Med. 2012;172(10):823-823. doi:10.1001/archinternmed.2012.836

We read with great interest the article by Uchino and Hernandez.1 By performing a meta-analysis of 7 randomized trials, they suggested that dabigatran therapy is associated with increased risk of myocardial infarction (MI) or acute coronary syndrome (ACS). Even though meta-analyses provide strong evidence for efficacy and safety, the role of chance should always be taken into account before definite conclusions.

First Page Preview View Large
First page PDF preview
First page PDF preview